After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
For long-term investing, focus on coins with clear use cases, strong teams, and growing demand. This guide highlights criteria to pick durable assets.
27,805 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
OpenAI CEO Sam Altman notes a sharp generational divide in how ChatGPT is used, with Millennials seeking personal fin...
A new survey finds a notable share of senior executives view data collection and use as ethically troubling, foreshad...
Air Force One diverted to Alaska to pick up NVIDIA CEO Jensen Huang on the way to a Beijing AI summit, marking a dram...
Three iShares ETFs have jumped more than 100% in 2026, led by chip-rich South Korea and Taiwan. This article breaks d...
With market volatility and shifting rates, many investors wonder if they should bond your portfolio. This guide break...
Cypherpunk Technologies reaffirms a 5% ZEC reserve despite a patched Zcash flaw, as investors debate the strategy ami...
A new tax window in 2026 may allow a retired couple to realize nearly six figures in long-term gains without federal ...
Retired couples can unlock cash from big gains without federal taxes by coordinating income and investments within th...
A quiet revolution is unfolding in AI infrastructure. This article explains why the stock market underestimating mass...
As Bloom Energy charts a post-2026 path, investors wonder if hydrogen fuel cells can sustain durable growth. This art...
Two popular US small-cap growth ETFs, ISCG and RZG, offer distinct paths to growth. This guide compares their strateg...